One sentence summary: The industrial strain produced significant amounts of isobutanol, but the secretion of the intermediate 2,3-dihydroxyisovalerate and the impossibility of its reuptake compromise isobutanol yield. Editor: Jens Nielsen ‡ Wesley Cardoso Generoso, http://orcid.org/0000-0002-5923-1458
INTRODUCTION
Isobutanol is being considered as a feasible fuel alternative among next-generation biofuels, and similarly to ethanol, isobutanol can also be produced fermentatively by microorganisms using renewable feedstocks (Dürre 2007; Buijs, Siewers and Nielsen 2013; Lan and Liao 2013) . Some characteristics make isobutanol a better alternative biofuel than ethanol, such as a higher combustion power, weaker corrosivity and reduced aqueous miscibility. Furthermore, if using the yeast Saccharomyces cerevisiae, which traditionally is used for commercial ethanol production, the current industrial infrastructure of ethanol Figure 1 . Schematic illustration of the engineered isobutanol biosynthetic pathway from glucose in recombinant S. cerevisiae. The scheme does not include reversible reactions, regulatory subunits and transcription factors. Continuous arrows stand for a single enzymatic step, arrows in bold for multiple enzymatic steps, dashed arrows for metabolite transport and dotted arrows for spontaneous reaction. For sake of clarity, the isobutanol production from xylose is not shown in this scheme. ALAC = 2-acetolactate; DIV = 2,3-dihydroxy-isovalerate; KIV = 2-ketoisovalerate. production plants could be employed (Petrovič 2015) . Saccharomyces cerevisiae naturally produces small amounts of isobutanol (as a 'fusel alcohol') in a combination of valine biosynthesis and the Ehrlich pathway (see Fig. 1 ). Briefly, two pyruvate molecules are condensed to 2-acetolactate, which is reduced and isomerized into 2,3-dihydroxyisovalerate (DIV), and further dehydrated to 2-ketoisovalerate (KIV). The endogenous pathway of S. cerevisiae is localized in the mitochondria and catalyzed by the enzymes Ilv2, Ilv5 and Ilv3, respectively. Afterwards, KIV is either transported into the cytosol or result of the cytosolic transamination of valine, then decarboxylated and reduced to isobutanol, by a ketoacid-decarboxylase (e.g. Aro10 in S. cerevisiae) and alcohol dehydrogenases (e.g. Adh2) (Vuralhan et al. 2005; Chen et al. 2011; Brat et al. 2012) . Nonetheless, the low endogenous production yield of isobutanol in yeast has stimulated research for optimization of this pathway (Generoso et al. 2015) . Moreover, this pathway is important for production of beer and wines, since the butter-like flavor is derived from acetoin and 2,3-butanediol, by-products from the Ilv pathway (Dasari and Kolling 2011) .
One of the limitations of the natural isobutanol production in yeast is the compartmentalization of the valine pathway inside mitochondria (Fig. 1) . In order to overcome the need for transport of pyruvate and KIV across the mitochondrial membrane, Brat et al. (2012) developed a fully cytosolic pathway for isobutanol production in yeast. For cytosolic localization of the Ilv enzymes, Brat et al. (2012) employed the N-terminally truncated mutants Ilv2 N54, Ilv5 N48 and Ilv3 N19. By additionally overexpressing Aro10 and Adh2, an isobutanol production yield up to 14.18 mg iso /g glu could be achieved. Milne et al. (2016) introduced the cytosolic isobutanol pathway into a pyruvate decarboxylasedeficient (Pdc -) strain to eliminate ethanol production as a major pathway competing for pyruvate in yeast. Surprisingly, this approach could not substantially increase isobutanol yields, due to accumulation of other by-products. Thereby, the low activity of the Ilv3 enzyme dihydroxyacid dehydratase (DHAD) was identified as a major bottleneck of the engineered isobutanol pathway.
In spite of these and other intensive efforts, the isobutanol production with yeast did not exceed 5% of the theoretical yield in the academic environment (Brat et al. 2012; Matsuda et al. 2013; Ida et al. 2015) , in which only laboratory yeast strains have been employed so far. Therefore, we wanted to investigate isobutanol production with a yeast strain derived from the industrial strain EthanolRed (Lesaffre, France), which is widely used for industrial ethanol production, due its excellent fermentation capacity, low by-product formation and its high tolerance to harsh conditions, such as low pH, high sugar concentration and high osmolarity (Mukhtar et al. 2010; Demeke et al. 2013) . Also, aiming to obtain a strain for use with plant biomass hydrolysates a posteriori, EthanolRed was first engineered for pentose consumption (Dietz 2013) .
Plant hydrolysates are complex slurries resulting from the depolymerization of cellulose and hemicellulose, and this material therefore contains not only glucose, but also substantial amounts of xylose and minor amounts of arabinose (Lynd et al. 2002) . Especially, fermentation of xylose by S. cerevisiae would improve the valorization of the feedstock. For this, S. cerevisiae must be enabled to convert xylose to xylulose, which is then phosphorylated and undergoes the non-oxidative pentosephosphate pathway (noPPP), resulting in glycolytic intermediates fructose-6-phosphate and glyceraldehyde-3-phosphate (Weber et al. 2010; Moyses et al. 2016) . This conversion can be either accomplished via two enzymatic redox steps, with xylitol as intermediate, or the direct isomerization. In this work, the xylose consuming strain employed as host for the isobutanol production converts xylose via direct isomerization (Dietz 2013) .
Therefore, the strategy adopted from Brat et al. (2012) was implemented for isobutanol production with this glucose and xylose consuming strain. The limitations of the isobutanol production were further investigated. Our results suggest that, together with the low activity of the cytosolic DHAD, the secretion of DIV ; pyk2::araA, araD, araB, araT, TAL2, TKL2, HXT7, RKI1, RPE1, TKL1, TAL1, XKS1, xylA; xylA, araB, araD, araA, pFBA1: GAL2; xylA, HXT9, araA, pPYK1: HXT2; unknown tpo2, tpo3, hxt9, hxt11, hxt12, yro2, mrh1, pdr12, hxt5, mch5, pdr5, pdr15, qdr2 B , qdr1 B , azr1, flr1, aqr1, arr3 and the inability of yeast for its reuptake further compromises the isobutanol yield. Therefore, microarray analyses were employed to identify candidate genes encoding proteins with DIV transport activity.
MATERIALS AND METHODS

Strains and media
Escherichia coli DH10B was used for general plasmid propagation. Saccharomyces cerevisiae Ethanol Red (Lesaffre, France) and CEN.PK113-7D strains were used in this work. Yeast strains are described in Table 1 and the used media were YPD (20 g/L peptone, 10 g/L yeast extract, 20 g/L carbon source), synthetic minimal medium (SM) (1.7 g/L yeast nitrogen base without amino acids (YNB), 5 g/L ammonium sulfate, 20 or 40 g/L carbon source, 20 mM potassium phosphate buffer, pH 6.3) and synthetic complex medium without valine (SC-V) (1.7 g/L YNB, 5 g/L ammonium sulfate, 20 or 40 g/L carbon source, pH 6.3, with addition of amino acids and nucleobases as described by Bruder et al. (2016) , but valine). The carbon sources used in the work were glucose (D), xylose (X), ethanol (E) and glycerol (G), and their concentrations in the media were 20 g/L for general propagations, and 40 g/L for fermentative tests. The cultivation was carried out at 30
• C with shaking and the fermentative tests were microaerobic, i.e. the flasks were sealed with airlocks filled with water. The antibiotics G418 (200 μg/mL) and nourseothricin (100 μg/mL) were added in the media for selection of kanMX4 and natNT2 markers, respectively.
Plasmid and strain construction
The plasmids were constructed with either the Gibson assembly (Gibson et al. 2009) or homologous recombination in yeast (Oldenburg et al. 1997) . The vectors were based on the singlecopy (pRS41 series) and multi-copy (pRS42 series) plasmids with kanMX4 or natNT2 markers. For the assembly, an overhang longer than 20 nucleotides was added to the 5 end of the primers. The sequences were retrieved from the Saccharomyces Genome and NCBI databases and amplified from the CEN.PK113-7D genomic DNA, plasmids of the laboratory and synthetic genes (Thermo Fisher Scientific, Germany). The genes ILV2 54, ILV3 19 and ilvC 6E6 were codon-optimized according to the codon usage of genes encoding glycolytic enzymes (Wiedemann and Boles 2008) and evaluated with the JCat software (Grote et al. 2005 ). The plasmids are described in Table 2 and the primer in Table S1 (Supporting Information). The sequences of the codon-optimized genes are presented in the supplementary material (Table S2 , Supporting Information). The yeast transformations were performed according to Gietz and Schiestl (2007) . The deletions were performed with the CRISPR/Cas9 system as described in Generoso et al. (2016) , and the protospacer and donor sequences are indicated in the Table S3 (supplementary material). OBS: Genes with co were codon optimized.
Growth test of the valine-auxotrophic strains
To evaluate KIV and DIV uptake, the strains WGY24, WGY54 and WGY55 were first plated on YPD agar plates, and then transferred to SCEG plates without valine, containing either 0.5 g/L KIV (cat# 198 994, Sigma-Aldrich, Germany) or 0.5 g/L DIV. The DIV used for the plates was produced in yeast cultures, whereby the supernatant of the fermentation of WGY.GISO1 was collected and directly used to supplement the agar plates.
Batch fermentations
For the microaerobic fermentations, cells were grown in 50 mL YPD at 30
• C, 180 RPM, until OD 600 = 3-4. Afterward, the cells were pelleted and transferred to 400 mL SMD or SCD-V medium at 30
• C, 180 RPM, until OD 600 = 3-5. After the growth, the culture was centrifuged at 5000 g for 15 min at room temperature, suspended in water and centrifuged once more, for washing. The pellet was resuspended in 50-100 mL SM or SC, with 40 g/L glucose or xylose, to a final OD 600 = 8. The cultures were transferred to 125 mL flasks and sealed with airlocks to achieve the microaerobic conditions. The fermentation was carried out at 30
• C on a magnetic stirrer and the supernatant was collected for HPLC analysis. The fermentations with the strain WGY.GISO1 were monitored periodically, while the fermentations for analysis of the deletion mutants were performed as end point, i.e. the fermentations were stopped after 12 h, when glucose was expected to be completely consumed.
Metabolite analysis
To analyze the metabolites in the fermentative tests, 450 μL of the culture supernatant were mixed with 50 μL 50% (w/v) 5-sulfosalicilic acid, for precipitation of the proteins, and centrifuged at 16 000 g for 5 min, 4
• C. From this supernatant, 10 μL was subjected to high-performance liquid chromatography (DionexUltimate 3000, ThermoScientific) equipped with the ion exchange column HyperREZ XP Carbohydrate H+ (7,7 × 300 mm; ThermoScientific) and a refractive index detector. The liquid phase was 5 mM sulfuric acid, run at 0.6 mL/min and 65
• C. The metabolites were quantified from standard curves of glucose, xylose, xylitol, ethanol, glycerol, isobutanol, acetate, acetoin, 2,3-butanediol, 2,3-dihydroxy-isovalerate, 2-ketoisovalerate and isobutyraldehyde. The Chromeleon 6.8 software was employed for quantifications and Prism 5 (GraphPad) for statistical analysis and presentation of the results.
Microarray analysis
The microarray analysis was performed with the strains WGY.GISO1 and WGY56. The strains were subjected to a microaerobic batch cultivation in SMD medium that was stopped when the glucose reached 15-10 g/L. The pellet of a 15 mL culture was used for RNA extraction. The pellet was transferred to 2 mL cryotubes containing 200 μL of acid-washed glass beads (0.5 mm in diameter) and 1 mL of the TRI Reagent (Sigma-Aldrich, Germany) and then vortexed for 10 min at 4
was added to the mixture, and incubated at room temperature for 5 min. The sample was centrifuged (12 000 g, 15 min, 4
• C) and the supernatant was further used for purification of the RNA using the RNeasy kit (Qiagen, Netherlands), following manufacturer's instructions. The quality control and quantification of the RNA were performed via agarose gel electrophoresis and spectrophotometry. Yeast OneArray R chip (Phalanx Biotech, USA) was employed for the array analysis with RNA of three independent cultivations. The labeling, hybridizations and data analysis were performed by Phalanx Biotech (USA).
RESULTS
Construction of an industrial isobutanol producing yeast strain
In this work, a xylose consuming industrial yeast strain was employed for integration of the isobutanol biosynthetic pathway. This strain, HDY.GUF12, derives from the yeast strain HDY.GUF5 (Demeke et al. 2013) . Additional expression constructs for enzymes involved in the isomerization of xylose, for uptake of arabinose, and additional sugar transporters were integrated into the genome of HDY.GUF5. This recombinant strain was then subjected to evolutionary engineering approaches carried out with media containing xylose and arabinose, and the resulting strain, HDY.GUF12, was able to ferment xylose efficiently and also demonstrated a stable and satisfactory performance even in lignocellulosic hydrolysates (Dietz 2013 ). This xylose consuming strain, HDY.GUF12, was further engineered for the production of isobutanol (Fig. 1) . For this, both ILV2 alleles were deleted, in order to abolish the mitochondrial ILV pathway. This strain was named WGY24. The enzymes of the isobutanol pathway were expressed in WGY24 from a centromeric plasmid (pWG108), which contained cassettes for overexpression of ILV2 54, ilvC 6E6 (Bastian et al. 2011), ILV3 19, ARO10 and ADH2, all under control of strong promoters (Tochigi et al. 2010). Microaerobic fermentations were carried out with this recombinant strain (WGY.GISO1) in SMD or SMX media, and the product yields presented in Fig. 2 were calculated at 10 h of fermentation with glucose, i.e. when glucose was almost completely consumed, and 24 h for the fermentation with xylose, when there was a change in the consumption pattern (Fig. S1 , Supporting Information). Significant amounts of isobutanol could be produced with the strain WGY.GISO1 (about 4 mg/g either with glucose or xylose); however, DIV was the main produced intermediate (Fig. 2) . The strain presented a slower consumption rate of xylose if compared to that of glucose (Fig.  S1 ), and we expected that this slower xylose consumption could contribute to balance the fluxes between glycolysis and the isobutanol pathway. Nonetheless, isobutanol yield was similar regardless of the sugar option. As the subsequent experiments did not depend on the carbon source, they were conducted with glucose only. DIV was the major secreted intermediate, while KIV and isobutanal were not detected (Fig. 2) . The enzyme responsible for conversion of DIV to KIV is Ilv3, a member of the IlvD-EDD family, which includes dehydratases containing iron-sulfur clusters (FeS) as cofactors. An improvement of Ilv3 enzymatic activity is an obvious target for the improvement of the engineered strain, and this is a subject of ongoing research. In this work, however, we focused on the transport of DIV across the plasma membrane. The identification of DIV transporters would be valuable to prevent the secretion of DIV and/or facilitate its reuptake.
DIV uptake and secretion by Saccharomyces cerevisiae
A notable characteristic of the isobutanol production in our engineered strain is the continuous production of DIV, which is not further consumed at late stages of the fermentation, in contrast to acetoin, which is converted to 2,3-butanediol afterwards (Fig. S3, Supporting Information) . Since the Ilv3 activity is unlikely to completely diminish after the exhaustion of glucose, we investigated whether this observation was a result of the inability of S. cerevisiae to reuptake DIV. For this, the branchedchain amino acid auxotrophic ilv2 deletion strain WGY24 was used for complementation assays in SCD-V but containing DIV or KIV as precursors for valine biosynthesis instead. Moreover, the cytosolic Ilv3 19 isoform was overexpressed in WGY24, in order to avoid the need for DIV transport across the mitochondrial membranes. As anticipated, the strain could not use DIV to complement the valine auxotrophy, and, surprisingly, KIV uptake and complementation was also very scarce (Fig. 3) . Growth with KIV could be improved by overexpression of the monocarboxylate symporter Jen1 (Casal et al. 1999) , demonstrating the requirement for a transporter-mediated uptake process. However, Jen1 did not confer growth with DIV, suggesting that this transporter is not able to transport DIV.
One alternative to avoid DIV wasting would be the retention of DIV inside of the cell. Therefore, in order to identify the transporters that could be responsible for DIV efflux, a comparative transcriptome analysis between a strain producing high amounts of DIV (WGY.GISO1) and a strain with basal DIV production (HDY.GUF12 carrying empty pRS41K, WGY56) was performed. The recombinant strains were employed for microaerobic fermentation in SMD medium, and the cultivation was stopped at the middle of the exponential growth phase (when approximately one half of glucose was consumed). The metabolites in the supernatant of the fermentations were analyzed to verify differential DIV production profiles (Fig. S2, Supporting Information) . The RNA was extracted from the cells and subjected to microarray hybridizations with Yeast OneArray R chip (Phalanx Biotech Group, USA). The microarray data are available in the ArrayExpress database (www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-5682. The majority of the transcripts presented similar expressing level in both conditions, and assuming a fold change (WGY.GISO1 versus WGY56, in log 2 scale) higher than 1.5, 348 genes were upregulated. Among these upregulated genes, more than 40% were genes with unknown function, and several related to mitochondrial functions. Interestingly, genes related to the branched-chain amino acids pathway (e.g. ILV1, BAT1, BAT2, LEU3) were not differentially expressed in both cases; however, 19 of these upregulated genes were related to transport of metabolites across the plasma membrane, although only 13 of these were implicated in transport of drugs and acids (Table 3 ). The other upregulated transporters (Table S4 , Supporting Information) were related to transport of amino acids, polypeptides and ions, and were not further investigated in this work. KIV (b) . The employed recombinant strains wereas follows: 1, WGY54; 2, WGY55; and 3, CEN.PK113-7D. The transformants were grown first in YPD containing the appropriate antibiotics, then shift to SCEG-V containing DIV or KIV. Images were taken from plates after 3 days of incubation at 30
• C. For simplicity, segments from different plates were merged into one figure. 
Investigation of the putative DIV transporters
In order to evaluate whether these (putative) transporters could be responsible for DIV efflux, the deletions of their genes, along with homologs or related genes, were carried out in CEN.PK113-7D. This haploid strain was chosen due to a simplicity of handling, and to avoid the need for the deletion of both alleles in the industrial EthanolRed-derived strain. Moreover, CEN.PK113-7D with ilv2 deletion (strain WGY21) showed the same phenomenon as WGY24, i.e. the inability to reuptake DIV (Fig. S3 , Supporting Information). The deletions were performed for each gene separately, and also all genes were deleted concomitantly in a single strain. Afterwards, the deletion mutants were transformed with the plasmid pWG108, and the transformants were subjected to microaerobic fermentation in SCD-V medium. In this case, the fermentations were performed with endpoint determinations, i.e. the fermentations were stopped and analyzed after 12 h of cultivation, when the glucose was expected to be completely consumed (Fig. S1 ). Unexpectedly, DIV efflux could not be abolished in any of the knockout strains (Fig. 4) . Nevertheless, six deletion strains, tpo2 tpo3, yro2 mrh1, qdr2 qdr1, azr1, flr1 and arr3, produced less DIV than the control. For sake of clarity, Fig. 4 only demonstrates the mutants in which either DIV yield was significantly reduced or isobutanol yield was significantly increased, control and all strain (the further results are shown in Fig. S4 , Supporting Information).
Interestingly, two mutants indicated potential involvement of the target genes in the DIV secretion: WGY.CISO1 yro2 mrh1 and WGY.CISO1 hxt5. In the fermentation results of the strain with knockout of YRO2/MRH1, the production yield of DIV was reduced by 40%, while an increase by 78.5% was observed for acetoin and 2,3-butanediol (as sum of both compounds), in comparison with the control (Fig. 4) . This might indicate that, due to a decrease in DIV secretion, more acetoin and 2,3-butanediol might accumulate. On the other hand, the fermentation with WGY.CISO1 hxt5 did not show significant differences in acetoin, 2,3-butanediol and DIV yields; however, the isobutanol yield was more than double of that of the control (Fig. 5) . Therefore, the same deletions were performed in the industrial strain, WGY.GISO1, and further investigated by microaerobic fermentations in SMD medium. Strikingly, the same tendency as observed in the WGY.CISO1 background was also observed in WGY.GISO1, although to a lower extent (Fig. 5) . The strain with the deletion of YRO2/MRH1 produced 10% less DIV, and 40% more acetoin and 2,3-butanediol than the control. For WGY.GISO1 hxt5, the isobutanol yield increased by 36.5% of the control value.
As transport systems in yeast are rather redundant, all 13 upregulated genes together with five homologs were deleted concomitantly in the strain WGY.CISO1, resulting in strain WGY.CISO1 all. Unexpectedly, the secretion of DIV, acetoin and 2,3-butanediol was slightly increased in this strain, whereas isobutanol yields were slightly decreased. This indicates and deletion mutants. The transformants were pre-grown in SCD-V with 20 g/L glucose, and the pelletwas used for the microaerobic fermentative tests at OD = 8 in SCD-V with 40 g/L glucose. The fermentations were performed with the strains WGY.CISO1 (control, white), WGY.CISO1 tpo2 tpo3 (red), WGY.CISO1 yro1 mrh1 (gray), WGY.CISO1 qdr2 qdr1 (blue), WGY.CISO1 azr1 (green), WGY.CISO1 flr1 (magenta), WGY.CISO1 arr3 (brown), WGY.CISO1 hxt5 (orange) and WGY.CISO1 all (dashed filled). The metabolite yields were calculated with the measurement at 12 h of cultivation. The mean values and mean deviations were calculated from two biological replicates. Asterisks indicate statistically significant differences (P < 0.05) compared to the control. DIV = 2,3-dihydroxy-isovalerate; Ace/2,3-BD = sum of acetoin and 2,3-butanediol. Figure 5 . Effect of transporter gene deletions on the isobutanol pathway in WGY.GISO1. The figure displays yields of the microaerobic fermentations with WGY.GISO1 and deletion mutants. The transformants were pre-grown in SMD with 20 g/L glucose, and the pellet was used for the microaerobic fermentative tests at OD = 8 in SMD with 40 g/L glucose. The fermentations were performed with the strains WGY.GISO1 (control, white), WGY.GISO1 yro1 mrh1 (gray) and WGY.GISO1 hxt5 (orange). The metabolite yields were calculated with the measurement at 12 h of cultivation. The mean values and mean deviations were calculated from two biological replicates. Asterisks indicate statistically significant differences (P < 0.05) compared to the control. DIV = 2,3-dihydroxy-isovalerate; Ace/2,3-BD = sum of acetoin and 2,3-butanediol.
compensatory effects of one of the other deletions compared to the secretion of DIV in the yro2 mrh1 deletion mutant. Indeed, already in an yro2 mrh1 tpo2 tpo3 quadruple deletion strain the decrease of the secretion of DIV was no longer observed (data not shown).
DISCUSSION
Isobutanol has some advantages among the possible biofuels of the future, and can be produced with microbial hosts. Although research with bacteria has already achieved the theoretical yield of production (Bastian et al. 2011) , the isobutanol synthesis using yeasts would better fit the current infrastructure for ethanol production. However, the highest isobutanol production yields reported for yeast are still lower than 5% of the theoretical yields (Matsuda et al. 2013) . Therefore, in our work, we focused not only on the development of an isobutanol producing strain, but also on the investigation of bottlenecks of this pathway. For this, the industrial strain EthanolRed (Lesaffre, France) was employed as host, due to its robustness in harsh industrial conditions (Mukhtar et al. 2010; Demeke et al. 2013) . Moreover, looking further ahead, we employed a derived strain engineered and evolved for efficient xylose consumption. Furthermore, as xylose consumption is normally slower than glucose consumption (Kuyper et al. 2005) , we expected a higher isobutanol production due to a better flux adjustment between glycolysis and the biosynthetic pathway. Moreover, this xylose consuming strain could be beneficial for isobutanol production in a final strain where ethanol formation is blocked by deletion of pyruvate decarboxylase genes. In Pdc -strains, reduced sugar consumption may prevent intracellular accumulation of inhibitory concentrations of pyruvate and may contribute to alleviation of the C-compound auxotrophy by release of glucose repression (Oud et al. 2012 ).
In our approach, a fully cytosolic pathway was employed for the isobutanol biosynthesis. Avalos, Fink and Stephanopoulos (2013) and Yuan and Ching (2015) demonstrated significant isobutanol production inside mitochondria, which was attributed to a higher local concentration of pathway intermediates and enzymes. However, the use of a mitochondrial pathway would cause limitations at the industrial scale, since mitochondria are strongly reduced in Saccharomyces cerevisiae under anaerobic cultivations or cultivation with high sugar concentrations (Watson, Haslam and Linnane 1970) . Therefore, the same biosynthetic pathway described by Brat et al. (2012) tian et al. 2011) , and its use would therefore balance the redox cofactor requirements of the pathway (Fig. 1) . Despite the use of the industrial strain and the NADH-dependent ketoacid reductoisomerase, the isobutanol production was lower than that reported by Brat et al. (2012) . However, the strain employed for isobutanol production by Brat et al. (2012) was further evolved for better growth in media without valine, which was not executed in this study. Interestingly, we observed that a high amount of DIV was produced during the fermentation, which could not be further consumed by the cells. Furthermore, high amounts of acetoin and 2,3-butanediol were measured in the fermentation, whereas neither KIV nor isobutyraldehyde was detected. This suggests that the dehydration step of the pathway, which is catalyzed by Ilv3, was limiting the pathway flux. The same notion was recently reported by Milne et al. (2016) in another strain background, however, only under aerobic conditions. Nonetheless, improvements of the DHAD activity is a subject on its own, due to the requirement of FeS cofactor, which could in turn be the responsible for the Ilv3 inefficiency. In yeast, initial FeS assembly occurs inside the mitochondria, and many details of this process are still unclear. It is known that more than 15 proteins are involved in the assembly and delivery of FeS clusters, and pursuits for improvement of FeS-dependent enzymes can be very challenging (Generoso et al. 2015) . Reasoning that keeping the pathway intermediates inside the cells would be beneficial to increase isobutanol yields, we attempted to identify transporters responsible for DIV secretion (and possibly its reuptake).
The passage of carboxylic acids through the plasma membrane can occur either passively, for protonated acids, or actively via transporters for the deprotonated acids (Casal et al. 2008) . Since the predicted pKa of DIV is 3.8 (Yeast Metabolome Database) and yeast cytosolic pH is around 7.2 (Orij et al. 2009 ), the export of DIV most likely occurs through transportermediated systems. Thus, the deletion of DIV transporters would confine DIV inside of the cell and potentially enhance isobutanol production. Considering that specific transporters are likely upregulated in cells overproducing DIV, we performed a microarray analysis to identify the corresponding genes. A set of 19 genes related to membrane transport was identified in the microarray analysis. Interestingly, the majority of them are related to transporters involved in multidrug resistance, e.g. TPO2, TPO3, HXT11, PDR12, PDR5, QDR2, AQR1, AZR1 and FLR1. As shown by analyzing DIV secretion by the corresponding deletion mutants, none of these 13 transporters (and their concomitantly deleted homologs) were responsible for DIV transport alone. Moreover, the cells deficient for all 18 transporter genes still secreted a high amount of DIV.
Nonetheless, the strains bearing the deletions of YRO2/MRH1 and HXT5 showed some beneficial effects. In fermentations with the YRO2/MRH1 deletion strain, a reduced DIV secretion was observed, with a concomitantly higher acetoin and 2,3-butanediol production. The higher accumulation of the former two intermediates can be explained by shifting the reaction equilibrium 'backwards' at a higher intracellular DIV concentration. Yro2 and Mrh1 are two homologous transporters involved in tolerance to weak acids in yeast. Single and double mutants were demonstrated to be more susceptible to acetate and lactate; however, only YRO2 transcription seemed to be responsive to weak acid stress (Keller et al. 2001; Takabatake, Kawazoe and Izawa 2015) . Nonetheless, the effect caused by YRO2 and MRH1 deletion seems to be dependent on the presence of other genes, since the reduced DIV yield observed for the yro2 mrh1 strains was completely annulled in the all deletion mutant, and already after deletion of TPO2 and TPO3.
On the other hand, Hxt5 is not related to transport of weak acid or drugs, but is instead a hexose transporter with low to moderate affinity for glucose, mainly expressed in the stationary phase or under non-fermentative regimes (Boles and Hollenberg 1997; Diderich et al. 2001) . Furthermore, hxt5 strains do not exhibit any clear growth phenotype, although HXT5 transcription seems to be trigged by different stress conditions (Gasch et al. 2000; Buziol et al. 2002; Verwaal et al. 2002) . Although a pleiotropic stress response could explain HXT5 upregulation in our experiment, the hxt5 deletion surprisingly led to a higher isobutanol production in two different strain backgrounds. This is unlikely due to a possibly altered glucose uptake, as we did not observe any significant delay of the glucose consumption (data not shown). Moreover, although fermentation of xylose exhibited a lower consumption rate, it did not lead to an enhancement of isobutanol production yield. Interestingly, the related transporters Hxt9 and Hxt11 (Nourani et al. 1997) as well as Hxt13 (Biswas et al. 2013) were implicated in different drug resistance processes, suggesting that, at least unspecifically, some Hxt transporters might transport substrates other than sugars.
Nonetheless, DIV efflux could not be completely abolished in our study, either because DIV secretion can be taken over by other transporters or our microarray strategy could not identify the main DIV transporter(s). Nevertheless, we could identify targets for further engineering isobutanol production, which, together with improvements of the DHAD activity, have the potential to increase isobutanol yields in yeast. Moreover, in an attempt to identify possible uptake systems, we could assess Jen1 as a KIV transporter, which was not yet described in the literature (Casal et al. 1999; McDermott, Rosen and Liu 2010) .
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